Clinical Trial Update: G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)

View source ↗

Summary

The G-PLUS post-treatment follow-up study (GALLANT, GALLEX, and ARMOR) sponsored by AstraZeneca has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Status: TERMINATED